期刊文献+

肾移植后不同时期转换为吗替麦考酚酯长期治疗的疗效观察 被引量:4

Clinical outcomes in renal allograft recipients switched to long-term immunosuppressive therapy withmycophenolate mofetil after renal transplantation
原文传递
导出
摘要 目的观察并评价肾移植后不同时期转换为吗替麦考酚酯(MMF)对受者肾功能的影响。方法多中心、非干预性观察研究,463例分为2组:Switch组(340例),肾移植6个月后转换为MMF治疗,转换起随访4年;Stay组(123例),肾移植后一直应用MMF治疗,入组后随访4年。2组内各分为4个亚群:A群,移植后6个月至1年转换(或入组);B群,移植后1—2年转换(或入组);C群,移植后2—5年转换(或入组);D群,移植5年后转换(或入组)。结果Switch组转换后受者的肾小球滤过率(GFR)明显改善,其斜率改变为3.1ml·min^-1·年。(P〈0.01);Stay组入组前后的GFR则保持稳定(P〉O.05)。Switch组各亚群间肾功能下降发生时间的差异有统计学意义(P〈0.01),B群最晚,D群最早;Stay组各亚群间的差异无统计学意义(P〉0.05)。Stay组肾功能正常者的比例每年均高出Switch组12%或以上。结论 肾移植6个月后至数年转换为MMF治疗,均可显著改善受者的。肾功能,越早转换越有利于肾功能的改善。移植后即持续MMF治疗有利于维持受者肾功能的稳定。 Objective To document the impact of conversion to mycophenolate mofetil (MMF) at different time points after transplantation on the renal function of renal function. Methods A long- term,multicenter, non-interventional and observational study was done. Two cohorts were included: One was Switch cohort (340 cases) including renal allograft recipients who switched to MMF at least 6 months after renal transplantation and followed up for 4 years after switch; The other was Stay cohort (123 cases), including renal allograft recipients who received MMF treatment after transplantation and followed up for 4 years after enrollment. Results GFR values of patients in Switch cohort was significantly increased after switch, and the change in GFR slope was 3.1 mL. min-1 · year-1 (P〈 0. 01). GFR values of patients in Stay cohort kept steady before and after enrollment, and the change in GFR slope was 0.44 mL.min-1· year-1 (P〉0. 05). Statistically significant difference in the onset time of GFR decline (defined as 20% decline from the baseline) was observed among subgroups within Switch cohort (P〈0. 01), but there was no significant difference among subgroups within Stay cohort (P〉0.05). Stay cohort was 12% higher than in Switch cohort every year. Conclusion Conversion to MMF 〉6 months or even many years after transplantation can obviously improve the renal function of recipients. The earlier conversion can benefit improvement of the renal function.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2012年第12期716-720,共5页 Chinese Journal of Organ Transplantation
关键词 吗替麦考酚酯 肾移植 钙调磷酸酶抑制剂 肾小球滤过率 Mycophenolate mofetil Kidney transplantation Calcineurin Glomerular Filtration Rate
  • 相关文献

参考文献10

  • 1Hariharan S,Johnson CP,Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med,2000,342(9):605-612.
  • 2Ojo OA, Hanson JA, Wolfe RA, et al. Long-term survival in renal transplant recipients with graft function. Kidney Int, 2000,57(1) :307-313.
  • 3Nankivell BJ,Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med, 2003, 349 (24) : 2326-2333.
  • 4Birnbaum LM, Lipman M, Paraskevas S, et al. Management of chronic allograft nephropathy: A systematic review. Clin J Am Soc Nephrol, 2009,4 (4) : 860-865.
  • 5Moore J, Middleton L, Cockwell P, et al. Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta analysis. Transplantation, 2009,87 (4) : 591-605.
  • 6Fleehner SM, Kobashigawa J, Klintmalm G. Calcineurin inhibitor-sparing regimens in solid organ transplantation:focus on improving renal function and nephrotoxicity. Clin Transplant,2008,22 (1) :1-15.
  • 7Kidney Disease: Improving Global Outcomes ( KDIGO ) Transplant Work Group. KDIGO Clinical Practice Gui. deline for the Care of Kidney Transplant recipients. Am J Transplant 2009,9 suppl 3 : S1-155.
  • 8Meier-Kriesche HU, Li S, Gruessner RW, et al. Immunosuppression: evolution in practice and trends, 1994- 2004. Am J Transplant, 2006,6 (5 Pt 2) : 1111-1131.
  • 9Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation. N Eng J Med,2007,357(25) :2562-2575.
  • 10Herwig-Ulf MK, Pierre M, Helio TS, et al. Mycophenolate Mofetil Initiation in Renal Transplant Patients at Different Times Posttransplantation: The TranCept Switch Study. Transplantation, 2011,91 (9) : 984-990.

同被引文献28

  • 1张春雨,江立,马满玲.泼尼松硫鸟嘌呤雷公藤联合治疗肾病综合征[J].药物流行病学杂志,2006,15(5):266-267. 被引量:3
  • 2Bilodeau JF,Montambault P, Wolff JL, et al. Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium[J]. Transplant Proc, 2009, 41(9): 3683-3689.
  • 3Salvadori M, Bertoni E, Budde K, et al. Superior efficacy of enteric-coated mycophenolate vs mycophenolate mofetil in de novo transplant recipients= pooled analysis [J]. Transplant Proc, 2010, 42(4): 1325-1328.
  • 4ReinkeP, Budde K, Hugo C, et al. Reduction of gastrointestinal complications in renal graft recipients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium [Jl. Transplant Proc, 2011, 43 (5) : 1641-1646.
  • 5Boric F, Glaise A, Pianta E, et al. Long-term quality of-life assessment of gastrointestinal symptoms before and after laparoscopic Nissen fundoplication [ J ]. Gastroenterol Clin Biol, 2010, 34(2)= 397-402.
  • 6Nakamura M, Hosoya Y, Umeshita K, et al. Postoperative quality of life: development and validation of the "Dysfunction After Upper Gastrointestinal Surgery" scoring system[J]. J Am Coll Surg, 2011, 213(4): 508-514.
  • 7Yeung SM, Shiu AT, Martin CR, et al. Translation and validation of the Chinese version of the Gastrointestinal Quality of Life Index in patients with gastric tumor[J]. J Psychosom Res, 2006,61 (4) : 469-477.
  • 8Chan L, Mulgaonkar S, Walker R, et al. Patient-reported gastrointestinal symptom burden and health-related quality of life following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium [J]. Transplantation, 2006, 81(9) : 1290-1297.
  • 9Maes BD, Dalle I, Geboes K, et al. Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea [-Jl. Transplantation, 2003, 75 (5) : 665-672.
  • 10Pietruck F, Abbud-Filho M, Vathsala A, et al. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable maintenance renal transplant patients: pooled results from three international, multieenter studies [J]. Transplant Proc, 2007, 39(1): 103-108.

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部